# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-19-005897
Filing Date
2019-03-28
Accepted
2019-03-28 16:31:33
Documents
6
Effectiveness Date
2019-03-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | nt10000663x1_defa14a.htm | DEFA14A | 15270
2 |  | nt10000663x1_logo01.jpg | GRAPHIC | 865631
3 |  | nt10000663x1_notice01.jpg | GRAPHIC | 123665
4 |  | nt10000663x1_notice02.jpg | GRAPHIC | 197960
5 |  | nt10000663x1_notice03.jpg | GRAPHIC | 103320
6 |  | nt10000663x1_notice04.jpg | GRAPHIC | 16701
| Complete submission text file | 0001140361-19-005897.txt |  | 1813125

Mailing Address 5255 VIRGINIA AVENUE NORTH CHARLESTON SC 29406
Business Address 5255 VIRGINIA AVENUE NORTH CHARLESTON SC 29406 8437402300
Ingevity Corp (Filer) CIK: 0001653477 (see all company filings)

EIN.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37586 | Film No.: 19712403
SIC: 2800 Chemicals & Allied Products